Immunology

Immunology Today—May 6, 2026

This week’s Immunology update highlights regulatory approvals, Phase 3…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804

Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal

Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…


Immunology

Immunology Video Recap—March 11, 2026

This biweekly Immunology video recap highlights regulatory approvals,…


Immunology

Immunology Today—March 11, 2026

This week’s Immunology update highlights regulatory progress, positive…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing

Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…


Immunology

Immunology Today—March 4, 2026

This week's Immunology update covers key regulatory actions, clinical trial…


Immunology

Immunology Video Recap—February 25, 2026

This biweekly Immunology video recap highlights key developments across…


Immunology

Immunology Today—February 25, 2026

This week's Immunology update summarizes covering clinical-trial readouts and…


ECCO 2026_Preview_by_LucidQuest

ECCO 2026 Preview: Key Crohn’s and Colitis Highlights to Watch

ECCO 2026 at a Glance Get ready for ECCO 2026. LucidQuest’s preview brings…


Immunology

Immunology Today—February 18, 2026

This week's Immunology update summarizes key developments in clinical trials,…


Public_Health

Public Health Video Recap—February 13, 2026

This biweekly Public Health video recap This biweekly Public Health video recap…


Privacy Preference Center